Login to Your Account

FDA Workshop Examines CFS; Hope for Hemispherx, Patients?

By Randy Osborne
Staff Writer

Thursday, March 7, 2013
Repurposing approved drugs – many of which already are being used for symptom relief – to give them official labels for chronic fatigue syndrome (CFS) will be one topic at an FDA-sponsored workshop next month on drug development for CFS and myalgic encephalomyelitis (ME).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription